+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Point of Care Diagnostics Market to 2027 - Global Analysis and Forecasts by Product, by Prescription Mode, End User and Geography

  • ID: 4841372
  • Report
  • Region: Global
  • 203 pages
  • The Insight Partners
1 of 3

FEATURED COMPANIES

  • Abbott
  • BD
  • Bio Rad Laboratories Inc.
  • bioMérieux SA
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd.
  • MORE
The global point of care diagnostics market is expected to reach US$ 70.89 Bn in 2027 from US$ 26.60 Bn in 2018. The market is estimated to grow with a CAGR of 11.8% from 2019-2027.

The market for point of care diagnostics is expected to grow, owing to factors such as increasing incidences of infectious diseases, product launches and product development and increasing number of CLIA-waived POC tests over the years. In addition, the emerging markets in developing countries are likely to have a positive impact on the growth of the market in the coming years. However, factors such as product recalls in market are likely to have a negative impact on the growth in the coming years.

POC testing is described as medical diagnostic testing at or near the point of care that is, at time and place of patient care. The purpose of POCT is to pro- vide immediate information to physicians about the patient's condition. Point of care testing (POCT) is an important diagnostic tool used in various locations in the hospital, in critical care settings such as the intensive care unit (ICU), the operating room (OR), and the emergency department (ED).

The product recalls in market may restrain the growth of the market during the forecast period. Global supply chains as well as increasingly stringent regulations. Recently, in 2018, PTS Panels CHOL+GLU test strips, which are the in vitro diagnostic medical devices (IVDs), were recalled in Australia due to due to the potential for loss of activity of the glucose analyte before the specified shelf life. According to the Department of Health, Therapeutic Goods Administration, these devices were produced by Point Of Care Diagnostics Australia Pty Ltd. Based on the results of internal testing, there was potential for under-recovery of the glucose analyte, and therefore, potential for lower results for the glucose test. This issue may result in the delay in diagnosis of diseases. Such events have hampered the customer confidence toward the use of point of care devices.

Global point of care diagnostics market is segmented by product, prescription mode, and end user. On the basis of product, the market is segmented into glucose monitoring products, infectious disease testing products, cardiometabolic testing products, pregnancy and fertility testing products, coagulation testing products, tumor/cancer marker testing products, cholesterol testing products, urinalysis testing products, hematology testing products, and other POC products. On the basis of prescription mode, the market is segmented into prescription-based testing and OTC testing. Based on end user, the market is segmented into professional diagnostic centers, home care, research laboratories, and others. In 2018, the glucose monitoring products segment held the largest share in the market, by product.

Some of the major primary and secondary sources included in the report are, Food and Drug Administration, World Health Organization, Public Health Agency of Canada, Canadian Diabetes Association, National Healthcare Safety Network (NHSN), International Diabetes Federation, Diabetes Education Society of South Africa (DESSA), Canadian Breast Cancer Foundation, National Cancer Institute (NCI), National Institute of Cancer Prevention and Research (NICPR), Pancreatic Cancer Network South Africa, and others.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Abbott
  • BD
  • Bio Rad Laboratories Inc.
  • bioMérieux SA
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd.
  • MORE
1. Introduction
1.1 Scope of the Study
1.2 Report Guidance
1.3 Market Segmentation
1.3.1 Global Point Of Care Diagnostics Market - By Product
1.3.2 Global Point Of Care Diagnostics Market - By Prescription Mode
1.3.3 Global Point Of Care Diagnostics Market - By End User
1.3.4 Global Point Of Care Diagnostics Market - By Geography

2. Global Point Of Care Diagnostics Market - Key Takeaways

3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Global Point of Care Diagnostics Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.2.2 Europe PEST Analysis
4.2.3 Asia Pacific PEST Analysis
4.2.4 Middle East & Africa PEST Analysis
4.2.5 South & Central America PEST Analysis

5. Global Point of Care Diagnostics Market - Key Industry Dynamics
5.1 Key Market Drivers
5.1.1 Increasing Incidences of Infectious Diseases
5.1.2 Product Launches and Product Developments
5.1.3 Increasing Number of CLIA-waived POC tests
5.2 Key Market Restraints
5.2.1 Product Recalls in Market
5.3 Key Market Opportunities
5.3.1 Emerging Markets in Developing Countries
5.3.2 Increasing Number of Conferences and Events
5.4 Future Trends
5.4.1 Increasing Use of Home-Based POC Devices
5.5 Impact Analysis

6. Point Of Care Diagnostics Market - Global Analysis
6.1 Global Point Of Care Diagnostics Market Revenue Forecasts And Analysis
6.2 Global Point Of Care Diagnostics Market, By Geography - Forecasts And Analysis
6.3 Performance of Key Players

7. Global Point Of Care Diagnostics Market Analysis- by Product
7.1 Overview
7.2 Global Point of Care Diagnostics Market, By Product 2018 & 2027 (%)
7.3 Glucose Monitoring Products Market
7.3.1 Overview
7.3.2 Global Glucose Monitoring Products Market Revenue and Forecasts to 2027 (US$ Mn)
7.4 Infectious Disease Testing Market
7.4.1 Overview
7.4.2 Global Infectious Disease Testing Market Revenue and Forecasts to 2027 (US$ Mn)
7.4.3 HIV Testing Products Market
7.4.3.1 Overview
7.4.3.2 Global HIV Testing Products Market Revenue and Forecasts to 2027 (US$ Mn)
7.4.4 Influenza Testing Products Market
7.4.4.1 Overview
7.4.4.2 Global Influenza Testing Products Market Revenue and Forecasts to 2027 (US$ Mn)
7.4.5 Sexually Transmitted Disease (STD) Testing Products Market
7.4.5.1 Overview
7.4.5.2 Global Sexually Transmitted Disease (STD) Testing Products Market Revenue and Forecasts to 2027 (US$ Mn)
7.4.6 Hepatitis C Testing Products Market
7.4.6.1 Overview
7.4.6.2 Global Hepatitis C Testing Products Market Revenue and Forecasts to 2027 (US$ Mn)
7.4.7 Healthcare-Associated Infection (HAI) Testing Products Market
7.4.7.1 Overview
7.4.7.2 Global Healthcare-Associated Infection (HAI) Testing Products Market Revenue and Forecasts to 2027 (US$ Mn)
7.4.8 Tropical Disease Testing Products Market
7.4.8.1 Overview
7.4.8.2 Global Tropical Disease Testing Products Market Revenue and Forecasts to 2027 (US$ Mn)
7.4.9 Respiratory Infection Testing Products Market
7.4.9.1 Overview
7.4.9.2 Global Respiratory Infection Testing Products Market Revenue and Forecasts to 2027 (US$ Mn)
7.4.10 Other Infectious Disease Products Market
7.4.10.1 Overview
7.4.10.2 Global Respiratory Infection Testing Products Market Revenue and Forecasts to 2027 (US$ Mn)
7.5 Cardiometabolic Testing Products Market
7.5.1 Overview
7.5.2 Global Cardiometabolic Testing Products Market Revenue and Forecasts to 2027 (US$ Mn)
7.6 Pregnancy And Fertility Testing Products Market
7.6.1 Overview
7.6.2 Global Pregnancy And Fertility Testing Products Market Revenue and Forecasts to 2027 (US$ Mn)
7.7 Coagulation Testing Products Market
7.7.1 Overview
7.7.2 Global Coagulation Testing Products Market Revenue and Forecasts to 2027 (US$ Mn)
7.8 Tumor/Cancer Marker Testing Products Market
7.8.1 Overview
7.8.2 Global Tumor/Cancer Marker Testing Products Market Revenue and Forecasts to 2027 (US$ Mn)
7.9 Cholesterol Testing Products Market
7.9.1 Overview
7.9.2 Global Cholesterol Testing Products Market Revenue and Forecasts to 2027 (US$ Mn)
7.10 Urinalysis Testing Products Market
7.10.1 Overview
7.10.2 Global Urinalysis Testing Products Market Revenue and Forecasts to 2027 (US$ Mn)
7.11 Haematology Testing Products Market
7.11.1 Overview
7.11.2 Global Haematology Testing Products Market Revenue and Forecasts to 2027 (US$ Mn)
7.12 Other POC Products Market
7.12.1 Overview
7.12.2 Global Other POC Market Revenue and Forecasts to 2027 (US$ Mn)

8. Global Point Of Care Diagnostics Market Analysis- by Prescription Mode
8.1 Overview
8.2 Global Point of Care Diagnostics Market, By Prescription Mode 2018 & 2027 (%)
8.3 Prescription-Based Testing Market
8.3.1 Overview
8.3.2 Global Prescription-Based Testing Market Revenue and Forecasts to 2027 (US$ Mn)
8.4 OTC Testing Market
8.4.1.1 Overview
8.4.1.2 Global OTC Testing Market Revenue and Forecasts to 2027 (US$ Mn)

9. Global Point Of Care Diagnostics Market Analysis- by End User
9.1 Overview
9.2 Global Point of Care Diagnostics Market, By End User 2018 & 2027 (%)
9.3 Professional Diagnostic Centers Market
9.3.1 Overview
9.3.2 Global Professional Diagnostic Centers Market Revenue and Forecasts to 2027 (US$ Mn)
9.4 Home Care Market
9.4.1 Overview
9.4.2 Global Home Care Market Revenue and Forecasts to 2027 (US$ Mn)
9.5 Research Laboratories Market
9.5.1 Overview
9.5.2 Global Research Laboratories Market Revenue and Forecasts to 2027 (US$ Mn)
9.6 Others Market
9.6.1 Overview
9.6.2 Global Others Market Revenue and Forecasts to 2027 (US$ Mn)

10. Point of Care Diagnostics Market Revenue and Forecasts to 2027 - Geographical Analysis
10.1 North America Point of Care Diagnostics Market Revenue And Forecasts To 2027
10.1.1 North America Point of Care Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.2 North America Point Of Care Diagnostics Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.1.2.1 North America Infectious Disease Testing Products Market Revenue And Forecasts To 2027, By Type (US$ MN)
10.1.3 North America Point Of Care Diagnostics Market Revenue And Forecasts to 2027, By Prescription Mode (US$ Mn)
10.1.4 North America Point Of Care Diagnostics Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.1.5 North America Point of Care Diagnostics Market Revenue and Forecasts to 2027, By Country (%)
10.1.6 US Point Of Care Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.6.1 US Point Of Care Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.6.2 US Point Of Care Diagnostics Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.1.6.2.1 US Infectious Disease Testing Products Market Revenue And Forecasts To 2027, By Type (US$ MN)
10.1.6.3 US Point of care diagnostics Market Revenue And Forecasts to 2027, By Prescription Mode (US$ Mn)
10.1.6.4 US Point of care diagnostics Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.1.7 Canada Point of care diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.7.1 Canada Point of care diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.7.2 Canada Point of care diagnostics Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.1.7.2.1 Canada Infectious Disease Testing Products Market Revenue And Forecasts To 2027, By Type (US$ MN)
10.1.7.3 Canada Point of care diagnostics Market Revenue And Forecasts to 2027, By Prescription Mode (US$ Mn)
10.1.7.4 Canada Point of care diagnostics Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.1.8 Mexico Point of care diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.8.1 Mexico Point of care diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.8.2 Mexico Point of care diagnostics Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.1.8.2.1 Mexico Infectious Disease Testing Products Market Revenue And Forecasts To 2027, By Type (US$ MN)
10.1.8.3 Mexico Point of care diagnostics Market Revenue And Forecasts to 2027, By Prescription Mode (US$ Mn)
10.1.8.4 Mexico Point of care diagnostics Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.2 Europe Point of Care Diagnostics Market Revenue And Forecasts To 2027
10.2.1 Europe Point of care diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.2 Europe Point of care diagnostics Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.2.2.1 Europe Infectious Disease Testing Products Market Revenue And Forecasts To 2027, By Type (US$ MN)
10.2.3 Europe Point of care diagnostics Market Revenue And Forecasts to 2027, By Prescription Mode (US$ Mn)
10.2.4 Europe Point of care diagnostics Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.2.5 Europe Point of care diagnostics Market Revenue and Forecasts to 2027, By Country (%)
10.2.6 UK Point of care diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.6.1 UK Point of care diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.6.2 UK Point of care diagnostics Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.2.6.2.1 UK Infectious Disease Testing Products Market Revenue And Forecasts To 2027, By Type (US$ MN)
10.2.6.3 UK Point of care diagnostics Market Revenue And Forecasts to 2027, By Prescription Mode (US$ Mn)
10.2.6.4 UK Point of care diagnostics Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.2.7 Germany Point of care diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.7.1 Germany Point of care diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.7.2 Germany Point of care diagnostics Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.2.7.2.1 Germany Infectious Disease Testing Products Market Revenue And Forecasts To 2027, By Type (US$ MN)
10.2.7.3 Germany Point of care diagnostics Market Revenue And Forecasts to 2027, By Prescription Mode (US$ Mn)
10.2.7.4 Germany Point of care diagnostics Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.2.8 France Point of care diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.8.1 France Point of care diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.8.2 France Point of care diagnostics Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.2.8.2.1 France Infectious Disease Testing Products Market Revenue And Forecasts To 2027, By Type (US$ MN)
10.2.8.3 France Point of care diagnostics Market Revenue And Forecasts to 2027, By Prescription Mode (US$ Mn)
10.2.8.4 France Point of care diagnostics Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.2.9 Italy Point of care diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.9.1 Italy Point of care diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.9.2 Italy Point of care diagnostics Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.2.9.2.1 Italy Infectious Disease Testing Products Market Revenue And Forecasts To 2027, By Type (US$ MN)
10.2.9.3 Italy Point of care diagnostics Market Revenue And Forecasts to 2027, By Prescription Mode (US$ Mn)
10.2.9.4 Italy Point of care diagnostics Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10.2.10 Spain Point of care diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.10.1 Spain Point of care diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.10.2 Spain Point of care diagnostics Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.2.10.2.1 Spain Infectious Disease Testing Products Market Revenue And Forecasts To 2027, By Type (US$ MN)
10.2.10.3 Spain Point of care diagnostics Market Revenue And Forecasts to 2027, By Prescription Mode (US$ Mn)
10.2.10.4 Spain Point of care diagnostics Market Revenue And Forecasts to 2027, By End User (US$ Mn)

11. Asia Pacific POC Diagnostics Market Revenue and Forecasts to 2027
11.1 Asia Pacific Point of Care Diagnostics Market Revenue And Forecasts To 2027
11.2 Asia Pacific Point of Care Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
11.2.1 Asia Pacific Point Of Care Diagnostics Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.2.1.1 Asia Pacific Infectious Disease Testing Products Market Revenue And Forecasts To 2027, By Type (US$ MN)
11.2.2 Asia Pacific Point Of Care Diagnostics Market Revenue And Forecasts to 2027, By Prescription Mode (US$ Mn)
11.2.3 Asia Pacific Point Of Care Diagnostics Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.2.4 Asia Pacific Point of Care Diagnostics Market Revenue and Forecasts to 2027, By Country (%)
11.2.5 Japan POC Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
11.2.5.1 Japan POC diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
11.2.5.2 Japan Point of Care Diagnostics Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.2.5.2.1 Japan Infectious Disease Testing Products Market Revenue And Forecasts To 2027, By Type (US$ MN)
11.2.5.3 Japan Point of care diagnostics Market Revenue And Forecasts to 2027, By Prescription Mode (US$ Mn)
11.2.5.4 Japan Point of care diagnostics Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.2.6 China POC Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
11.2.6.1 China Point of Care Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
11.2.6.2 China Point of care diagnostics Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.2.6.2.1 China Infectious Disease Testing Products Market Revenue And Forecasts To 2027, By Type (US$ MN)
11.2.6.3 China Point of care diagnostics Market Revenue And Forecasts to 2027, By Prescription Mode (US$ Mn)
11.2.6.4 China Point of Care Diagnostics Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.2.7 India Point of Care Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
11.2.7.1 India Point of Care Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
11.2.7.2 India Point of Care Diagnostics Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.2.7.2.1 India Infectious Disease Testing Products Market Revenue And Forecasts To 2027, By Type (US$ MN)
11.2.7.3 India Point of care diagnostics Market Revenue And Forecasts to 2027, By Prescription Mode (US$ Mn)
11.2.7.4 India Point of care diagnostics Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.2.8 South Korea POC Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
11.2.8.1 South Korea Point of Care Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
11.2.8.2 South Korea Point of care diagnostics Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.2.8.2.1 South Korea Infectious Disease Testing Products Market Revenue And Forecasts To 2027, By Type (US$ MN)
11.2.8.3 South Korea Point of care diagnostics Market Revenue And Forecasts to 2027, By Prescription Mode (US$ Mn)
11.2.8.4 South Korea Point of Care Diagnostics Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.2.9 Australia POC diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
11.2.9.1 Australia Point of Care Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
11.2.9.2 Australia Point of care diagnostics Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.2.9.2.1 Australia Infectious Disease Testing Products Market Revenue And Forecasts To 2027, By Type (US$ MN)
11.2.9.3 Australia Point of care diagnostics Market Revenue And Forecasts to 2027, By Prescription Mode (US$ Mn)
11.2.9.4 Australia Point of care diagnostics Market Revenue And Forecasts to 2027, By End User (US$ Mn)

12. MEA
12.1 Middle East & Africa Point of care Diagnostics Market Revenue And Forecasts To 2027
12.1.1 Middle East & Africa Point of care Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
12.1.2 Middle East & Africa Point of Care Diagnostics Market Revenue And Forecasts to 2027, By Product (US$ Mn)
12.1.2.1 Middle East & Africa Infectious Disease Testing Products Market Revenue And Forecasts To 2027, By Type (US$ MN)
12.1.3 Middle East & Africa Point of care diagnostics Market Revenue And Forecasts to 2027, By Prescription Mode (US$ Mn)
12.1.4 Middle East & Africa Point of care diagnostics Market Revenue And Forecasts to 2027, By End User (US$ Mn)
12.1.5 Middle East & Africa Point of care Diagnostics Market Revenue and Forecasts to 2027, By Country (%)
12.1.6 UAE Point of care Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
12.1.6.1 UAE Point of care Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
12.1.6.2 UAE Point of care diagnostics Market Revenue And Forecasts to 2027, By Product (US$ Mn)
12.1.6.2.1 UAE Infectious Disease Testing Products Market Revenue And Forecasts To 2027, By Type (US$ MN)
12.1.6.3 UAE Point of care diagnostics Market Revenue And Forecasts to 2027, By Prescription Mode (US$ Mn)
12.1.6.4 UAE Point of Care Diagnostics Market Revenue And Forecasts to 2027, By End User (US$ Mn)
12.1.7 Saudi Arabia Point of care Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
12.1.7.1 Saudi Arabia Point of care Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
12.1.7.2 Saudi Arabia Point of care diagnostics Market Revenue And Forecasts to 2027, By Product (US$ Mn)
12.1.7.2.1 Saudi Arabia Infectious Disease Testing Products Market Revenue And Forecasts To 2027, By Type (US$ MN)
12.1.7.3 Saudi Arabia Point of care diagnostics Market Revenue And Forecasts to 2027, By Prescription Mode (US$ Mn)
12.1.7.4 Saudi Arabia Point of care diagnostics Market Revenue And Forecasts to 2027, By End User (US$ Mn)
12.1.8 South Africa Point of care Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
12.1.8.1 South Africa Point of care Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
12.1.8.2 South Africa Point of Care Diagnostics Market Revenue And Forecasts to 2027, By Product (US$ Mn)
12.1.8.2.1 South Africa Infectious Disease Testing Products Market Revenue And Forecasts To 2027, By Type (US$ MN)
12.1.8.3 South Africa Point of care diagnostics Market Revenue And Forecasts to 2027, By Prescription Mode (US$ Mn)
12.1.8.4 South Africa Point of care diagnostics Market Revenue And Forecasts to 2027, By End User (US$ Mn)

13. SCAM
13.1 South And Central America Point of care diagnostics Market Revenue And Forecasts To 2027
13.1.1 South and Central America Point of care diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
13.1.2 South and Central America Point of Care Diagnostics Market Revenue And Forecasts to 2027, By Product (US$ Mn)
13.1.2.1 South and Central America Infectious Disease Testing Products Market Revenue And Forecasts To 2027, By Type (US$ MN)
13.1.3 South and Central America Point of care diagnostics Market Revenue And Forecasts to 2027, By Prescription Mode (US$ Mn)
13.1.4 South and Central America Point of care diagnostics Market Revenue And Forecasts to 2027, By End User (US$ Mn)
13.1.5 South and Central America Point of care diagnostics Market Revenue and Forecasts to 2027, By Country (%)
13.1.6 Argentina Point of care diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
13.1.6.1 Argentina Point of Care Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
13.1.6.2 Argentina Point of care diagnostics Market Revenue And Forecasts to 2027, By Product (US$ Mn)
13.1.6.2.1 Argentina Infectious Disease Testing Products Market Revenue And Forecasts To 2027, By Type (US$ MN)
13.1.6.3 Argentina Point of care diagnostics Market Revenue And Forecasts to 2027, By Prescription Mode (US$ Mn)
13.1.6.4 Argentina Point of care diagnostics Market Revenue And Forecasts to 2027, By End User (US$ Mn)
13.1.7 Brazil Point of care diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
13.1.7.1 Brazil Point of care diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
13.1.7.2 Brazil Point of care diagnostics Market Revenue And Forecasts to 2027, By Product (US$ Mn)
13.1.7.2.1 Brazil Infectious Disease Testing Products Market Revenue And Forecasts To 2027, By Type (US$ MN)
13.1.7.3 Brazil Point of care diagnostics Market Revenue And Forecasts to 2027, By Prescription Mode (US$ Mn)
13.1.7.4 Brazil Point of care diagnostics Market Revenue And Forecasts to 2027, By End User (US$ Mn)

14. Point of Care Diagnostics Market - Industry Landscape
14.1 Overview
14.2 Growth Strategies in the Point of care diagnostics market, 2016-2019
14.3 Organic Growth Strategies
14.3.1 Overview
14.3.2 Product Approval
14.3.3 Product Launch
14.3.4 Expansions
14.4 Inorganic Growth Strategies
14.4.1 Overview
14.4.2 Agreement
14.4.3 Acquisition
14.4.4 Partnership & Collaboration

15. Point Of Care Diagnostics Market-Key Company Profiles
15.1 F. Hoffmann-La Roche Ltd.
15.1.1 Key Facts
15.1.2 Business Description
15.1.3 Financial Overview
15.1.4 Product Portfolio
15.1.5 SWOT Analysis
15.1.6 Key Developments
15.2 Abbott
15.2.1 Key Facts
15.2.2 Business Description
15.2.3 Financial Overview
15.2.4 Product Portfolio
15.2.5 SWOT Analysis
15.2.6 Key Developments
15.3 Siemens
15.3.1 Key Facts
15.3.2 Business Description
15.3.3 Financial Information
15.3.4 Product Portfolio
15.3.5 SWOT Analysis
15.3.6 Key Developments
15.4 BD
15.4.1 Key Facts
15.4.2 Business Description
15.4.3 Financial Information
15.4.4 Product Portfolio
15.4.5 SWOT Analysis
15.4.6 Key Developments
15.5 Polymer Technology Systems, Inc. (PTS DIAGNOSTICS)
15.5.1 Key Facts
15.5.2 Business Description
15.5.3 Financial Information
15.5.4 Product Portfolio
15.5.5 SWOT Analysis
15.5.6 Key Developments
15.6 Johnson & Johnson Services, Inc.
15.6.1 Key Facts
15.6.2 Business Description
15.6.3 Financial Overview
15.6.4 Product Portfolio
15.6.5 SWOT Analysis
15.6.6 Key Developments
15.7 Nova Biomedical
15.7.1 Key Facts
15.7.2 Business Description
15.7.3 Financial Overview
15.7.4 Product Portfolio
15.7.5 SWOT Analysis
15.7.6 Key Developments
15.8 bioMérieux SA
15.8.1 Key Facts
15.8.2 Business Description
15.8.3 Financial Information
15.8.4 Product Portfolio
15.8.5 SWOT Analysis
15.8.6 Key Developments
15.9 Bio-Rad Laboratories, Inc.
15.9.1 Key Facts
15.9.2 Business Description
15.9.3 Financial Information
15.9.4 Product Portfolio
15.9.5 SWOT Analysis
15.9.6 Key Developments
15.10 Danaher
15.10.1 Key Facts
15.10.2 Business Description
15.10.3 Financial Overview
15.10.4 Product Portfolio
15.10.5 SWOT Analysis
15.10.6 Key Developments

16. Appendix
16.1 About the Publishers
16.2 Glossary Of Terms
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • F. Hoffmann-La Roche Ltd.
  • Danaher Corporation
  • Bio Rad Laboratories Inc.
  • Abbott
  • bioMérieux SA
  • Johnson & Johnson Services, Inc.
  • Nova Biomedical
  • Siemens AG
  • BD
  • PTS Diagnostics
Note: Product cover images may vary from those shown
Adroll
adroll